NASDAQ: ELTX
Elicio Therapeutics Inc Stock Ownership - Who owns Elicio Therapeutics?

Insider buying vs selling

Have Elicio Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Peter DemuthChief Scientific Officer2025-12-09362$4.41
$1.60kBuy

1 of 1

ELTX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELTX insiders and whales buy or sell their stock.

ELTX Shareholders

What type of owners hold Elicio Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Yekaterina Chudnovsky28.38%5,416,212$15.17MInsider
Eisaabc LLC14.36%2,740,978$7.67MInsider
Itzhak Goldberg8.84%1,687,986$4.73MInsider
Victor F. Ganzi5.13%978,698$2.74MInsider
Knoll Capital Management LLC3.31%630,915$1.77MInstitution
Vanguard Capital Management LLC2.72%518,638$1.45MInstitution
Balyasny Asset Management LP1.28%244,814$685.48kInstitution
Jay Venkatesan0.95%180,534$505.50kInsider
Geode Capital Management LLC0.71%135,164$378.46kInstitution
Renaissance Technologies LLC0.64%121,631$340.57kInstitution

1 of 3

ELTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELTX13.83%59.76%Net Buying
XLO7.00%93.00%Net Selling
INKT0.52%99.48%Net BuyingNet Buying
MREO9.45%4.17%
CNTX86.17%1.43%

Elicio Therapeutics Stock Ownership FAQ

Who owns Elicio Therapeutics?

Elicio Therapeutics (NASDAQ: ELTX) is owned by 13.83% institutional shareholders, 59.76% Elicio Therapeutics insiders, and 26.41% retail investors. Yekaterina Chudnovsky is the largest individual Elicio Therapeutics shareholder, owning 5.42M shares representing 28.38% of the company. Yekaterina Chudnovsky's Elicio Therapeutics shares are currently valued at $15.17M.

If you're new to stock investing, here's how to buy Elicio Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.